{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:11:04Z","timestamp":1784927464981,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e19527","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:04:44Z","timestamp":1693569884000},"page":"e19527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of impacts of aspirin therapy versus placebo on preeclampsia: An observational study"],"prefix":"10.1016","volume":"9","author":[{"given":"Liping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e19527_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib2","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of pre-eclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population-based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e19527_bib4","first-page":"2146","article-title":"Association between placenta previa and risk of hypertensive disorders of pregnancy: a meta-analysis based on 7 cohort studies","volume":"19","author":"Yin","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2023.e19527_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19527_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med. Aug 17"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19527_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jch.12541","article-title":"Low\u2010Dose aspirin for preventing preeclampsia and its complications: a meta\u2010analysis","volume":"17","author":"Xu","year":"2015","journal-title":"J. Clin. Hypertens."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19527_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and foetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2020.03.038","article-title":"Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: a randomized controlled trial from Shanghai, China","volume":"248","author":"Gu","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.heliyon.2023.e19527_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for pre-eclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.heliyon.2023.e19527_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1975.tb00710.x","article-title":"A critical evaluation of sonar \u201ccrown-rump length\u201d measurements","volume":"82","author":"Robinson","year":"1975","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000335366","article-title":"Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation","volume":"31","author":"Poon","year":"2012","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.heliyon.2023.e19527_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib15","series-title":"Hypertension in Pregnancy: the Management of Hypertensive Disorders during Pregnancy","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e19527_bib16","first-page":"1122","article-title":"Hypertension in pregnancy: report of the American college of obstetricians and gynaecologists' Task Force on hypertension in pregnancy","volume":"122","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib18","article-title":"Competing risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of pre-eclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of pre-eclampsia and foetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e19527_bib22","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2169\/internalmedicine.50.5294","article-title":"Clopidogrel treatment during pregnancy: a case report and a review of literature","volume":"50","author":"Santis","year":"2011","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19527_bib23","article-title":"Aspirin for the prevention of preeclampsia: a systematic review and meta-analysis of randomized controlled studies","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med. Nov 9"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e19527_bib24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive Services Task Force recommendation statement","volume":"326","year":"2021","journal-title":"JAMA"},{"issue":"2S","key":"10.1016\/j.heliyon.2023.e19527_bib25","first-page":"S1108","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2020","journal-title":"Am J Obstet Gynecol. 2022 Feb"},{"key":"10.1016\/j.heliyon.2023.e19527_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.36129\/jog.32.02.05","article-title":"The role of serum potassium and sodium levels in the development of postpartum hemorrhage. A retrospective study","volume":"32","author":"Privitera","year":"2020","journal-title":"Italian J. Gynaecol. Obstetrics"},{"key":"10.1016\/j.heliyon.2023.e19527_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-021-04294-z","article-title":"The role of endoglin and its soluble form in pathogenesis of preeclampsia","volume":"477","author":"Margioula-Siarkou","year":"2022","journal-title":"Mol. Cell. Biochem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402306735X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402306735X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:58:24Z","timestamp":1784926704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402306735X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S240584402306735X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19527","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of impacts of aspirin therapy versus placebo on preeclampsia: An observational study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19527"}}